Migraine drug trial halted midway
NCT ID NCT07116499
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called K-645 for people having a migraine attack. It aimed to see if the drug could stop pain and other bothersome symptoms better than a placebo. The trial was stopped early, so results are limited. About 134 adults with a history of migraine were planned to take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APD Clinical Research
Splendora, Texas, 77372, United States
-
Albuquerque Clinical Trials, Inc.
Albuquerque, New Mexico, 87102, United States
-
Chicago Headache Center and Research Institute
Chicago, Illinois, 60657, United States
-
Clinical Research Associates, Inc.
Nashville, Tennessee, 37203, United States
-
Clinical Research Atlanta - Stockbridge
Stockbridge, Georgia, 30281, United States
-
Clinical Research Institute
Minneapolis, Minnesota, 55402, United States
-
Collective Medical Research
Overland Park, Kansas, 66202, United States
-
DM Clinical Research - Bellaire
Houston, Texas, 77081, United States
-
DelRicht Research - Atlanta
Atlanta, Georgia, 30329, United States
-
DelRicht Research - Prairieville
Prairieville, Louisiana, 70817, United States
-
Dent Neurosciences Research Center
Amherst, New York, 14226, United States
-
Excell Research, Inc.
Oceanside, California, 92056, United States
-
Headache Wellness Center
Greensboro, North Carolina, 27405, United States
-
Health Research of Hampton Roads, Inc.
Newport News, Virginia, 23606, United States
-
L-MARC Research Center
Louisville, Kentucky, 40213, United States
-
OK Clinical Research, LLC
Edmond, Oklahoma, 73034, United States
-
Peters Medical Research
High Point, North Carolina, 27260, United States
-
SPRI Clinical Trials, LLC
Brooklyn, New York, 11235, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.